In this study we evaluated the effect of two different doses of secretin on portal haemodynamics (by pulsed Doppler associated with real time ultrasound) in 24 healthy humans. In 12 subjects (group A) we administered an intravenous dose of 75 clinical units of secretin and in the remaining 12 (group B) a dose of 20 CU. In all subjects the following parameters were studied before, during, and for 10 minutes after secretin administration: (a) 
L Bolondi, S Gaiani, S Li Bassi, G Zironi, P Casanova, L Barbara Abstract In this study we evaluated the effect of two different doses of secretin on portal haemodynamics (by pulsed Doppler associated with real time ultrasound) in 24 healthy humans. In 12 subjects (group A) we administered an intravenous dose of 75 clinical units of secretin and in the remaining 12 (group B) a dose of 20 CU. In all subjects the following parameters were studied before, during, and for 10 Jp-m --1 (127-6%) and group B (114%) with no significant difference between the two groups.
In the subjects in which superior mesenteric artery was studied basal values of flow were 227 8iW10 (29) 25 injection. This behaviour is closely similar to the sources of errors with this method were response of the main pancreatic duct to secretin in a cautionary review by Gill'9 and stimulation29 and may suggest a direct effect of ered by Burns and Glucagon, a polypeptide with structural similarity to secretin33 (each sharing a 14 amino acid sequence), has been shown to induce splanchnic vasodilatation and increase portal venous pressure. On the basis of experimental studies this effect seems to be a result of an increase in both inflow volume3435 and intrahepatic portal resistance.7 It is unlikely that this hormone has a physiological role in postprandial hyperaemia since the release of glucagon depends mainly on a substantial drop in plasma glucose concentrations, and a glucose containing meal causes a decrease rather than an increase of serum glucagon.36 It has been suggested that cholecystokinin, which increases portal venous blood flow and portal venous pressure in dogs,'0 is the most likely candidate for increasing intestinal blood flow in the postprandial state.37 Secretin may add to the known effect of cholecystokinin on postprandial blood flow in a similar way to their combined effect on pancreatic exocrine function.
As far as this problem is concerned the final question is to establish if the observed effect of secretin on portal flow is only pharmacological or even physiological. The significant increase of portal vein and superior mesenteric arterial flow observed after the lower dose ofsecretin (20 CU), which corresponds to less than one third of the dose used to stimulate the maximal exocrine pancreatic secretion, shows a high sensitivity of the splanchnic vascular bed to secretin stimulation. This might suggest a role for secretin in the modulation of postprandial splanchnic hyperaemia. This point cannot, however, be established from our data and further investigation is needed to confirm this hypothesis.
